R-Pharm spoke about plans to deliver the vaccine to many countries

This was told on the air "Russia 24" the chairman of the board of directors and founder of "R-Farm" Alexei Repik.

“We formalized this intention in the form of a signed agreement on the production and supply of a vaccine developed by AstraZeneca and Oxford University, using R-Pharm's technological capabilities to implement the project,” he said.

Repik added that R-Pharm will play the role of “a kind of hub for the supply of vaccines to a huge number of countries - to 30-50 countries."

“Including the countries of the Middle East, including the countries of Southeast Asia, Europe, naturally the CIS and Russia ... Naturally, Russia is always a top priority for us,” he said.

Earlier, the head of the RDIF, Kirill Dmitriev, said that AstraZeneca agreed with R-Pharm on the production of the vaccine and has already transferred all the developments.